{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T19:56:19Z","timestamp":1770148579337,"version":"3.49.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Heparin is used in humans as prophylaxis of hypercoagulable states and disseminated intravascular coagulation (DIC). However, babies need a higher heparin dose than do adults. Septic neonate foals are at high risk of hypercoagulable state and DIC, and there is limited objective information about heparin dose for equine neonates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess whether neonate foals require higher dosages of low-molecular-weight heparin (LMWH) than adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Eighteen healthy and 11 septic neonate foals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Experimental and clinical studies. Firstly, healthy foals were randomly distributed in 2 groups, 1 receiving 50\u2003IU\/kg SC of dalteparin and the 2nd group receiving 100\u2003IU\/kg SC of dalteparin, once daily for 3 days. Blood samples were collected before and 3, 6, 27, and 51 hours after the 1st LMWH administration. Plasma antifactor-Xa activity was measured, together with hemostatic and hematologic parameters used to assess the risk of bleeding. Subsequently, septic foals were treated blindly either with placebo (saline) or 100\u2003IU\/kg of dalteparin for 3 days. Plasma antifactor-Xa activity and other hemostatic parameters were determined before and after treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Plasma antifactor-Xa activity in healthy foals was below prophylactic activity when using the adult dosage (50\u2003IU\/kg), whereas prophylactic activities were achieved when using the double dosage (100\u2003IU\/kg). No hemorrhagic events and erythrocyte-related complications were observed with either dosage. In the clinical study, only 4\/6 septic foals had plasma antifactor-Xa activity adequate for prophylaxis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>Equine neonates require higher dosages of LMWH compared with adults to reach prophylactic heparinemia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1939-1676.2010.0568.x","type":"journal-article","created":{"date-parts":[[2010,8,2]],"date-time":"2010-08-02T19:24:17Z","timestamp":1280777057000},"page":"1190-1195","source":"Crossref","is-referenced-by-count":19,"title":["Low-Molecular-Weight Heparin Dosage in Newborn Foals"],"prefix":"10.1093","volume":"24","author":[{"given":"L.","family":"Armengou","sequence":"first","affiliation":[{"name":"Servei de Medicina Interna Equina, Departament de Medicina i Cirurgia Animals, Facultat de Veterin\u00e0ria, Universitat Aut\u00f2noma de Barcelona , Barcelona,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Monreal","sequence":"additional","affiliation":[{"name":"Servei de Medicina Interna Equina, Departament de Medicina i Cirurgia Animals, Facultat de Veterin\u00e0ria, Universitat Aut\u00f2noma de Barcelona , Barcelona,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.\u00c1.","family":"Delgado","sequence":"additional","affiliation":[{"name":"Servei de Medicina Interna Equina, Departament de Medicina i Cirurgia Animals, Facultat de Veterin\u00e0ria, Universitat Aut\u00f2noma de Barcelona , Barcelona,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"R\u00edos","sequence":"additional","affiliation":[{"name":"Laboratory of Biostatistics & Epidemiology, Universitat Aut\u00f2noma de Barcelona, Statistics and Methodology Support Unit, IDIBAPS, Hospital Cl\u00ednic , Barcelona,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Cesarini","sequence":"additional","affiliation":[{"name":"Servei de Medicina Interna Equina, Departament de Medicina i Cirurgia Animals, Facultat de Veterin\u00e0ria, Universitat Aut\u00f2noma de Barcelona , Barcelona,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Jose-Cunilleras","sequence":"additional","affiliation":[{"name":"Servei de Medicina Interna Equina, Departament de Medicina i Cirurgia Animals, Facultat de Veterin\u00e0ria, Universitat Aut\u00f2noma de Barcelona , Barcelona,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2010,9,1]]},"reference":[{"key":"2026020303164191700_b1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1053\/jcrc.2001.30666","article-title":"Pathogenesis and treatment of disseminated intravascular coagulation in the septic patient","volume":"16","author":"Levi","year":"2001","journal-title":"J Crit Care"},{"key":"2026020303164191700_b2","first-page":"595","article-title":"Current Therapy in Equine Medicine","author":"Paradis","year":"1997","edition":"4th ed"},{"key":"2026020303164191700_b3","first-page":"142","article-title":"Coagulation, fibrinolytic and kallikrein systems in neonates with uncomplicated sepsis and septic shock","volume":"23","author":"Rom\u00e1n","year":"1993","journal-title":"Haemostasis"},{"key":"2026020303164191700_b4","doi-asserted-by":"crossref","first-page":"R82","DOI":"10.1186\/cc2459","article-title":"Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism","volume":"8","author":"Kinasewitz","year":"2004","journal-title":"Crit Care"},{"key":"2026020303164191700_b5","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1378\/chest.104.3.882","article-title":"Double-blind, placebo-controlled trial of antothrombotin III concentrates in septic shock with disseminated intravascular coagulation","volume":"104","author":"Fourrier","year":"1993","journal-title":"Chest"},{"key":"2026020303164191700_b6","first-page":"531","article-title":"Neonatal sepsis","volume":"25","author":"Kreuz","year":"1999","journal-title":"A challenge in hemostaseology"},{"key":"2026020303164191700_b7","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/BF02759894","article-title":"Acute renal failure in neonatal sepsis","volume":"73","author":"Mathur","year":"2006","journal-title":"Indian J Pediatr"},{"key":"2026020303164191700_b8","first-page":"543","article-title":"Distribution patterns of microthrombi in disseminated intravascular coagulation","volume":"107","author":"Shimamura","year":"1983","journal-title":"Arch Pathol Lab Med"},{"key":"2026020303164191700_b9","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJM199908193410807","article-title":"Disseminated intravascular coagulation","volume":"341","author":"Levi","year":"1999","journal-title":"N Engl J Med"},{"key":"2026020303164191700_b10","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1182\/blood.V96.7.2329","article-title":"Modulation of hemostatic mechanisms in bacterial infectious diseases","volume":"96","author":"Tapper","year":"2000","journal-title":"Blood"},{"key":"2026020303164191700_b11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1939-1676.1998.tb00493.x","article-title":"Hemostatic and fibrinolytic indices in neonatal foals with presumed septicemia","volume":"12","author":"Barton","year":"1998","journal-title":"J Vet Intern Med"},{"key":"2026020303164191700_b12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1939-1676.2008.0050.x","article-title":"Plasma D-dimer concentration in sick newborn foals","volume":"22","author":"Armengou","year":"2008","journal-title":"J Vet Intern Med"},{"key":"2026020303164191700_b13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1939-1676.2008.0229.x","article-title":"Prospective evaluation of coagulation in critically ill neonatal foals","volume":"23","author":"Bentz","year":"2009","journal-title":"J Vet Intern Med"},{"key":"2026020303164191700_b14","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/j.1939-1676.2008.0178.x","article-title":"Fibrin deposits and organ failure in newborn foals with severe septicemia","volume":"22","author":"Cotovio","year":"2008","journal-title":"J Vet Intern Med"},{"key":"2026020303164191700_b15","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1164\/ajrccm.164.10.2105027","article-title":"Coagulation blockade prevents sepsis-induced respiratory and renal failure in baboons","volume":"164","author":"Welty-Wolf","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020303164191700_b16","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/00001721-199410000-00022","article-title":"Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers","volume":"5","author":"Asakura","year":"1994","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2026020303164191700_b17","first-page":"887S","article-title":"Antithrombotic therapy in neonates and children","volume":"133","author":"Monagle","year":"2008","journal-title":"American College of Chest Physicians evidence-based clinical practice guidelines (8th edn)"},{"key":"2026020303164191700_b18","first-page":"1337","article-title":"Thrombosis in the critically ill neonate","volume":"4","author":"Veldman","year":"2008","journal-title":"Incidence, diagnosis, and management"},{"key":"2026020303164191700_b19","first-page":"826","article-title":"Enoxaparin for neonatal thrombosis","volume":"122","author":"Malowany","year":"2008","journal-title":"A call for a higher dose for neonates"},{"key":"2026020303164191700_b20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.2042-3292.1993.tb00984.x","article-title":"Possible hypercoagulation in 3 foals with septicaemia","volume":"5","author":"Darien","year":"1993","journal-title":"Equine Vet Educ"},{"key":"2026020303164191700_b21","first-page":"26","article-title":"Heparin","volume":"8","author":"Moore","year":"1994","journal-title":"A review of its pharmacology and therapeutic use in horses"},{"key":"2026020303164191700_b22","first-page":"506","article-title":"Comparison of unfractioned and low molecular weight heparin for prophylaxis of coagulopathies in 52 horses with colic","volume":"35","author":"Feige","year":"2003","journal-title":"A randomised double-blind clinical study"},{"key":"2026020303164191700_b23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1939-1676.1992.tb00982.x","article-title":"Disseminated intravascular coagulation associated with colic in 23 horses (1984\u20131989)","volume":"6","author":"Welch","year":"1992","journal-title":"J Vet Intern Med"},{"key":"2026020303164191700_b24","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1939-1676.2007.tb02965.x","article-title":"Detection of fibrin deposits in tissues from horses with severe gastrointestinal disorders","volume":"21","author":"Cotovio","year":"2007","journal-title":"J Vet Intern Med"},{"key":"2026020303164191700_b25","first-page":"313","article-title":"Low-molecular-weight heparin in pediatric patients with thrombotic disease","volume":"128","author":"Massicotte","year":"1996","journal-title":"A dose finding study"},{"key":"2026020303164191700_b26","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.siny.2006.01.005","article-title":"Neonatal thromboembolic emergencies","volume":"11","author":"Thornburg","year":"2006","journal-title":"Semin Fetal Neonatal Med"},{"key":"2026020303164191700_b27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0049-3848(03)00100-2","article-title":"Dose-finding and pharmacokinetic profiles of prophylactic doses of a low molecular weight heparin (reviparin\u2013sodium) in pediatric patients","volume":"109","author":"Massicotte","year":"2003","journal-title":"Thromb Res"},{"key":"2026020303164191700_b28","doi-asserted-by":"crossref","first-page":"868","DOI":"10.2460\/ajvr.2002.63.868","article-title":"Comparison of pharmacokinetic variables for two low-molecular-weight heparins after subcutaneous administration of a single dose to horses","volume":"63","author":"Schwarzwald","year":"2002","journal-title":"Am J Vet Res"},{"key":"2026020303164191700_b29","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2460\/ajvr.1995.56.10.1281","article-title":"Comparison of the effect of low-molecular-weight and unfractioned heparin in horses","volume":"56","author":"Monreal","year":"1995","journal-title":"Am J Vet Res"},{"key":"2026020303164191700_b30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.2042-3306.1988.tb01445.x","article-title":"Development of a scoring system for the early diagnosis of equine neonatal sepsis","volume":"20","author":"Brewer","year":"1988","journal-title":"Equine Vet J"},{"key":"2026020303164191700_b31","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.2460\/javma.1986.189.11.1478","article-title":"Erythrocyte agglutination associated with heparin treatment in three horses","volume":"189","author":"Mahaffey","year":"1986","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303164191700_b32","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2460\/ajvr.1987.48.01.68","article-title":"Heparin-induced agglutination of erythrocytes in horses","volume":"48","author":"Moore","year":"1987","journal-title":"Am J Vet Res"},{"issue":"5","key":"2026020303164191700_b33","first-page":"106","article-title":"Description of an in vitro platelet function analyzer\u2014the PFA-100TM","volume":"21","author":"Kundu","year":"1995","journal-title":"Sem Thromb Haemost"},{"key":"2026020303164191700_b34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/107602969600200404","article-title":"Characterization of an in vitro platelet function analyser, the PFA-100TM","volume":"2","author":"Kundu","year":"1996","journal-title":"Clin Appl Thromb Hemost"},{"key":"2026020303164191700_b35","first-page":"108","article-title":"Assessment of a platelet function analyser in horses","volume":"170","author":"Segura","year":"2005","journal-title":"Reference range and influence of a platelet aggregation inhibitor"},{"key":"2026020303164191700_b36","first-page":"1129","article-title":"Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients","volume":"31","author":"Huo","year":"2009","journal-title":"A review"},{"key":"2026020303164191700_b37","first-page":"57","article-title":"Low molecular weight heparins","volume":"543","author":"Barrowcliffe","year":"1988","journal-title":"Antithrombotic and haemorrhagic effects and standardization"},{"key":"2026020303164191700_b38","first-page":"179","article-title":"Comparative study on the antithrombotic efficacy of hirudin, heparin and low-molecular-weight heparin in preventing experimentally induced venous thrombosis","volume":"23","author":"Monreal","year":"1993","journal-title":"Haemostasis"},{"key":"2026020303164191700_b39","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1177\/104063879500700314","article-title":"Hemostatic indices in healthy foals from birth to one month of age","volume":"7","author":"Barton","year":"1995","journal-title":"J Vet Diagn Invest"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1939-1676.2010.0568.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/24\/5\/1190\/66654700\/j.1939-1676.2010.0568.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/24\/5\/1190\/66654700\/j.1939-1676.2010.0568.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T08:16:59Z","timestamp":1770106619000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/24\/5\/1190\/8447357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,1]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,9,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1939-1676.2010.0568.x","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2010,9]]},"published":{"date-parts":[[2010,9,1]]}}}